Cirmtuzumab, An Anti-Ror1 Antibody, In Combination With Ibrutinib: Clinical Activity In Mantle Cell Lymphoma (Mcl) Or Chronic Lymphocytic Leukemia (Cll) From A Phase 1/2 StudyHun Ju Lee,Michael Y. Choi,Tanya Siddiqi,William G. Wierda,Jacqueline C. Barrientos,Nicole Lamanna,Alec Goldenberg,Iris Isufi,Joseph Tuscano,Suki Subbiah,Jean L. Koff,Lori A. Leslie,Gina G Chung,Elizabeth K Weihe,Xen Ianopulos,James B. Breitmeyer,Frank J Hsu,Michael Wang,Catriona Jamieson,Thomas J. KippsBLOOD（2020）引用 7|浏览60暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
